Zydus said the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in the 12-18-year age group. India to Get 2nd Home-Grown Covid Vaccine? Zydus Cadila Seeks Approval for 3-Dose Shot
Zydus said the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in the 12-18-year age group. India to Get 2nd Home-Grown Covid Vaccine? Zydus Cadila Seeks Approval for 3-Dose Shot
No comments:
Post a Comment